These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17258458)

  • 1. Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors.
    Rong F; Chow S; Yan S; Larson G; Hong Z; Wu J
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1663-6. PubMed ID: 17258458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Gopalsamy A; Lim K; Ellingboe JW; Krishnamurthy G; Orlowski M; Feld B; van Zeijl M; Howe AY
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4221-4. PubMed ID: 15261274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
    Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation.
    Ryu K; Kim ND; Choi SI; Han CK; Yoon JH; No KT; Kim KH; Seong BL
    Bioorg Med Chem; 2009 Apr; 17(8):2975-82. PubMed ID: 19332375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Gopalsamy A; Aplasca A; Ciszewski G; Park K; Ellingboe JW; Orlowski M; Feld B; Howe AY
    Bioorg Med Chem Lett; 2006 Jan; 16(2):457-60. PubMed ID: 16274990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase.
    Hendricks RT; Spencer SR; Blake JF; Fell JB; Fischer JP; Stengel PJ; Leveque VJ; Lepogam S; Rajyaguru S; Najera I; Josey JA; Swallow S
    Bioorg Med Chem Lett; 2009 Jan; 19(2):410-4. PubMed ID: 19070486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new 4,5-dihydrofuranoindoles and their evaluation as HCV NS5B polymerase inhibitors.
    Velázquez F; Venkatraman S; Lesburg CA; Duca J; Rosenblum SB; Kozlowski JA; Njoroge FG
    Org Lett; 2012 Jan; 14(2):556-9. PubMed ID: 22220815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Lai VC; Zhong W; Wu JZ
    Bioorg Med Chem Lett; 2005 Feb; 15(3):675-8. PubMed ID: 15664835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.
    Nichols DB; Leão RA; Basu A; Chudayeu M; de Moraes Pde F; Talele TT; Costa PR; Kaushik-Basu N
    Chem Biol Drug Des; 2013 May; 81(5):607-14. PubMed ID: 23311976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.
    You L; Cho EJ; Leavitt J; Ma LC; Montelione GT; Anslyn EV; Krug RM; Ellington A; Robertus JD
    Bioorg Med Chem Lett; 2011 May; 21(10):3007-11. PubMed ID: 21478016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
    Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
    Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase.
    Donner PL; Xie Q; Pratt JK; Maring CJ; Kati W; Jiang W; Liu Y; Koev G; Masse S; Montgomery D; Molla A; Kempf DJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2735-8. PubMed ID: 18362072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase.
    Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Wu JZ; Yao N
    Bioorg Chem; 2006 Feb; 34(1):26-38. PubMed ID: 16360193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.
    Chan L; Reddy TJ; Proulx M; Das SK; Pereira O; Wang W; Siddiqui A; Yannopoulos CG; Poisson C; Turcotte N; Drouin A; Alaoui-Ismaili MH; Bethell R; Hamel M; L'Heureux L; Bilimoria D; Nguyen-Ba N
    J Med Chem; 2003 Apr; 46(8):1283-5. PubMed ID: 12672227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents.
    Zhou Y; Li LS; Dragovich PS; Murphy DE; Tran CV; Ruebsam F; Webber SE; Shah AM; Tsan M; Averill A; Showalter RE; Patel R; Han Q; Zhao Q; Hermann T; Kissinger CR; Lebrun L; Sergeeva MV
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1419-24. PubMed ID: 18226901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
    McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
    Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.
    Rockway TW; Zhang R; Liu D; Betebenner DA; McDaniel KF; Pratt JK; Beno D; Montgomery D; Jiang WW; Masse S; Kati WM; Middleton T; Molla A; Maring CJ; Kempf DJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3833-8. PubMed ID: 16650984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.